Florexa
Product Images NDC 82160-125

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Florexa (NDC 82160-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pella Pharmaceuticals Co. Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Primary Package (Primary Package..)

Primary Package (Primary Package..)
This is a product description for a medication called Florexa, which contains Eflornithine HCl (13.9%) and is used for topical use. The medication is manufactured by Pella Pharmaceuticals Co.ltd. Jordan and comes in a 1g container. The text also includes dosage information and instructions to store the medication below 30°C, read the enclosed leaflet before use, and keep it out of reach of children. The Pantone numbers (438 and 437) and the black color information likely refer to packaging or labeling design.*
FDA Label Image

Secondary Package (Secondary Package..)

Secondary Package (Secondary Package..)
This is a label for a product containing Eflornithine HCI 13.9%. The text mentions the color codes Pantone 438 and Pantone 437, and "Black". It also includes the manufacturer's name, LaRI Pella Pharmaceuticals Co. Ltd. and a warning to store the product below 30°C and keep it out of reach of children. There are some illegible text and characters that couldn't be identified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.